Pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Unichem Laboratories has informed that it enclosed the result of remote e-voting in the prescribed format along with Scrutinizer's consolidated report for the below resolutions which were proposed for the approval of the Members through Postal Ballot. a. Appointment of Anand Kusre (DIN 00818477) as a Non-Executive Independent Director for a term of five years with effect from 5th February 2024, b. Appointment of Arun Todarwal (DIN 00020916) as a Non-Executive Independent Director for a term of five years with effect from 5th February 2024, c. Material related party transaction(s) with Ipca Laboratories (‘Ipca’), holding company of Unichem Laboratories, d. Material related party transaction(s) between Ipca, holding company of Unichem and Unichem Pharmaceuticals USA Inc. (‘Unichem USA’), wholly owned subsidiary of Unichem, e. Material related party transaction(s) with Unichem USA, wholly owned subsidiary of Unichem. The resolutions as proposed in the postal ballot notice have been passed by the shareholders by remote e-voting process with requisite majority and are deemed to be passed on the last date of the remote e-voting period i.e. Friday, 22nd March 2024. The said results and the scrutinizer’s report will be available on the Company’s website: www.unichemlabs.com and that of the exchanges namely www.bseindia.com and www.nseindia.com and the website of the e-voting agency: www.evotingindia.com.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1650.75 |
| Dr. Reddys Lab | 1323.90 |
| Cipla | 1288.90 |
| Zydus Lifesciences | 937.20 |
| Lupin | 2331.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: